Is the iShares Core S&P Total U.S. Stock Market ETF the Best Broad Market Fund?

Schwab U.S. Broad Market ETF (SCHB) and iShares Core S&P Total U.S. Stock Market ETF (ITOT) are nearly identical on fees, yield, and risk, both charging 0.03% with roughly 1.0% dividend yields and 1.01 betas. ITOT is much larger at $91.1B in AUM versus SCHB's $42.1B, while five-year max drawdown is the same at -25.4% for both. The article frames the decision as mostly issuer preference or brokerage availability rather than a fundamental difference in exposure.

Analysis

The real takeaway is not that these two funds are interchangeable; it is that passive U.S. market exposure is now so crowded into a handful of mega-cap platforms that “total market” is effectively a disguised concentration trade. With Apple, Microsoft, and Nvidia dominating both wrappers, investors buying broad diversification are implicitly underwriting the durability of the AI/platform capex cycle and the multiple support those names provide to the entire index complex.

That creates a second-order loser set: active large-cap managers, equal-weight strategies, and any benchmark-relative portfolio that is underweight the same mega-cap cohort. If the handful of dominant names stumble, the perceived safety of broad beta can unwind quickly because the concentration is high enough that a small number of stocks can drive most of the drawdown, even in a fund that holds thousands of names.

The near-identical risk metrics also imply the main edge is flow, not fundamentals. AUM migration into the larger vehicle can become self-reinforcing through tighter trading spreads and institutional default selection, but the alpha is minimal unless one is exploiting brokerage, rebalancing, or tax-location constraints. The more interesting trade is not SCHB versus ITOT; it is whether to own the index at all versus expressing the mega-cap leadership theme directly.

Contrarian view: the market is paying for diversification while actually buying concentration at a low fee. That may still be rational if rates remain stable and the AI capex cycle keeps earnings revisions positive, but if real yields rise or leadership narrows, these funds will behave less like broad-market ballast and more like leveraged proxies for the largest tech balance sheets.

Key Decisions for Investors

• Do not rotate between SCHB and ITOT for alpha; use whichever has better brokerage/operational fit and treat the choice as immaterial over a 6-12 month horizon.
• For directional exposure, prefer a basket of AAPL/MSFT/NVDA over the total-market ETF if the objective is to express AI/platform leadership; use a 3-6 month window and size modestly because index-level downside can still be driven by these same names.
• Pair trade idea: long equal-weight S&P 500, short a small notional of total-market beta via ITOT/SCHB, targeting 3-6 months if mega-cap concentration starts to mean-revert; risk is continued narrow leadership in AI winners.
• Use any 5-10% pullback in NVDA or MSFT to add selectively rather than adding to passive broad-market exposure; the ETF wrapper hides the same concentration without giving better entry points.
• If real yields move higher by 50 bps or more over the next 1-2 quarters, hedge total-market exposure with QQQ puts or a short NDX overlay, since the implicit factor load is more tech-heavy than most investors assume.